Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: IMARC | PRODUCT CODE: 1701870

Cover Image

PUBLISHER: IMARC | PRODUCT CODE: 1701870

Recombinant Protein Market Report by Product, Application, End User, and Region 2025-2033

PUBLISHED:
PAGES: 146 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 2999
PDF & Excel (5 User License)
USD 3999
PDF & Excel (Corporate License)
USD 4999

Add to Cart

The global recombinant protein market size reached USD 2.1 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 5.0 Billion by 2033, exhibiting a growth rate (CAGR) of 9.55% during 2025-2033.

A recombinant protein refers to a modified or altered protein that is encoded by recombinant DNA. The recombinant DNA molecule consists of a plasmid in which the genes for a target protein are cloned. It is produced either by molecular cloning or polymerase chain reaction (PCR). Some of the common product variants include kinase proteins, human insulin, structural proteins, adhesion molecules and receptors, immune response proteins, etc. Recombinant protein is primarily utilized in the development of novel therapies for chronic and rare diseases. It finds widespread adoption in numerous biopharmaceutical companies, academic and research institutes, contract research organizations, etc.

Recombinant Protein Market Trends:

The elevating prevalence of several chronic diseases along with the increasing demand for novel treatment options is primarily driving the global recombinant protein market. In addition to this, the rising investments in the field of protein engineering and the improving focus on protein-based drug development are further augmenting the market growth. Moreover, numerous government bodies are funding R&D activities for the introduction of advanced techniques in proteomics and genomics, which are significantly impacting the global market for recombinant protein. Besides this, the advent of recombinant protein expression technology has led to the development of high-quality autoantigens that are widely used in immunotherapy procedures. Additionally, the growing requirement for recombinant proteins for accurate measurement of biomarkers in the field of drug discovery is also creating a positive outlook for the global market. Apart from this, the rising penetration of latest molecular biology approaches for biopharming to reduce proteolysis of recombinant proteins or prevent the partial or total loss of glycosylation is expected to bolster the global recombinant protein market over the forecast period.

Key Market Segmentation:

Breakup by Product:

  • Antibodies
  • Hormones
  • Growth Factors
  • Cytokines
  • Others

Breakup by Application:

  • Drug Discovery and Development
  • Academic Research
  • Biotechnology Research
  • Biopharmaceutical Production
  • Others

Breakup by End User:

  • Pharmaceutical and Biopharmaceutical Companies
  • Biotechnology Companies
  • Academic and Research Institutes
  • Contract Research Organization
  • Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abcam plc, Amgen Inc., Bio-RAD Laboratories Inc., Bio-Techne Corporation, Bps Bioscience Inc., Enzo Biochem Inc., Genscript Biotech Corporation, Merck KGaA, Novo Nordisk A/S, ProSpec-Tany TechnoGene Ltd, Sanofi S.A. and Thermo Fisher Scientific.

Key Questions Answered in This Report

  • 1.What was the size of the global recombinant protein market in 2024?
  • 2.What is the expected growth rate of the global recombinant protein market during 2025-2033?
  • 3.What are the key factors driving the global recombinant protein market?
  • 4.What has been the impact of COVID-19 on the global recombinant protein market?
  • 5.What is the breakup of the global recombinant protein market based on application?
  • 6.What is the breakup of the global recombinant protein market based on the end user?
  • 7.What are the key regions in the global recombinant protein market?
  • 8.Who are the key players/companies in the global recombinant protein market?
Product Code: SR112025A6079

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Recombinant Protein Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Antibodies
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Hormones
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Growth Factors
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Cytokines
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Others
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Drug Discovery and Development
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Academic Research
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Biotechnology Research
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Biopharmaceutical Production
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Pharmaceutical and Biopharmaceutical Companies
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Biotechnology Companies
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Academic and Research Institutes
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Contract Research Organization
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Abcam plc
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Amgen Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Bio-RAD Laboratories Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Bio-Techne Corporation
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
    • 14.3.5 Bps Bioscience Inc.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 Enzo Biochem Inc.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Genscript Biotech Corporation
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
    • 14.3.8 Merck KGaA
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Novo Nordisk A/S
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 ProSpec-Tany TechnoGene Ltd
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
    • 14.3.11 Sanofi S.A.
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis
    • 14.3.12 Thermo Fisher Scientific
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials
      • 14.3.12.4 SWOT Analysis
Product Code: SR112025A6079

List of Figures

  • Figure 1: Global: Recombinant Protein Market: Major Drivers and Challenges
  • Figure 2: Global: Recombinant Protein Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Recombinant Protein Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Recombinant Protein Market: Breakup by Product (in %), 2024
  • Figure 5: Global: Recombinant Protein Market: Breakup by Application (in %), 2024
  • Figure 6: Global: Recombinant Protein Market: Breakup by End User (in %), 2024
  • Figure 7: Global: Recombinant Protein Market: Breakup by Region (in %), 2024
  • Figure 8: Global: Recombinant Protein (Antibodies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: Recombinant Protein (Antibodies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: Recombinant Protein (Hormones) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Recombinant Protein (Hormones) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Recombinant Protein (Growth Factors) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Recombinant Protein (Growth Factors) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Recombinant Protein (Cytokines) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Recombinant Protein (Cytokines) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Recombinant Protein (Other Products) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Recombinant Protein (Other Products) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Recombinant Protein (Drug Discovery and Development) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Recombinant Protein (Drug Discovery and Development) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Recombinant Protein (Academic Research) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Recombinant Protein (Academic Research) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Recombinant Protein (Biotechnology Research) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Recombinant Protein (Biotechnology Research) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Recombinant Protein (Biopharmaceutical Production) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Recombinant Protein (Biopharmaceutical Production) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: Global: Recombinant Protein (Other Applications) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: Global: Recombinant Protein (Other Applications) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: Global: Recombinant Protein (Pharmaceutical and Biopharmaceutical Companies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: Global: Recombinant Protein (Pharmaceutical and Biopharmaceutical Companies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: Global: Recombinant Protein (Biotechnology Companies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: Global: Recombinant Protein (Biotechnology Companies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: Global: Recombinant Protein (Academic and Research Institutes) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: Global: Recombinant Protein (Academic and Research Institutes) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: Global: Recombinant Protein (Contract Research Organization) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: Global: Recombinant Protein (Contract Research Organization) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: Global: Recombinant Protein (Other End Users) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: Global: Recombinant Protein (Other End Users) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: North America: Recombinant Protein Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: North America: Recombinant Protein Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: United States: Recombinant Protein Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: United States: Recombinant Protein Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: Canada: Recombinant Protein Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: Canada: Recombinant Protein Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: Asia-Pacific: Recombinant Protein Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: Asia-Pacific: Recombinant Protein Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: China: Recombinant Protein Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: China: Recombinant Protein Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: Japan: Recombinant Protein Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: Japan: Recombinant Protein Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: India: Recombinant Protein Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: India: Recombinant Protein Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: South Korea: Recombinant Protein Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: South Korea: Recombinant Protein Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: Australia: Recombinant Protein Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: Australia: Recombinant Protein Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: Indonesia: Recombinant Protein Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: Indonesia: Recombinant Protein Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: Others: Recombinant Protein Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: Others: Recombinant Protein Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: Europe: Recombinant Protein Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: Europe: Recombinant Protein Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Germany: Recombinant Protein Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Germany: Recombinant Protein Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: France: Recombinant Protein Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: France: Recombinant Protein Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: United Kingdom: Recombinant Protein Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: United Kingdom: Recombinant Protein Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Italy: Recombinant Protein Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Italy: Recombinant Protein Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Spain: Recombinant Protein Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Spain: Recombinant Protein Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Russia: Recombinant Protein Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Russia: Recombinant Protein Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 74: Others: Recombinant Protein Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 75: Others: Recombinant Protein Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 76: Latin America: Recombinant Protein Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 77: Latin America: Recombinant Protein Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 78: Brazil: Recombinant Protein Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 79: Brazil: Recombinant Protein Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 80: Mexico: Recombinant Protein Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 81: Mexico: Recombinant Protein Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 82: Others: Recombinant Protein Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 83: Others: Recombinant Protein Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 84: Middle East and Africa: Recombinant Protein Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 85: Middle East and Africa: Recombinant Protein Market: Breakup by Country (in %), 2024
  • Figure 86: Middle East and Africa: Recombinant Protein Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 87: Global: Recombinant Protein Industry: SWOT Analysis
  • Figure 88: Global: Recombinant Protein Industry: Value Chain Analysis
  • Figure 89: Global: Recombinant Protein Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Recombinant Protein Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Recombinant Protein Market Forecast: Breakup by Product (in Million USD), 2025-2033
  • Table 3: Global: Recombinant Protein Market Forecast: Breakup by Application (in Million USD), 2025-2033
  • Table 4: Global: Recombinant Protein Market Forecast: Breakup by End User (in Million USD), 2025-2033
  • Table 5: Global: Recombinant Protein Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: Recombinant Protein Market: Competitive Structure
  • Table 7: Global: Recombinant Protein Market: Key Players
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!